Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2418015 | 1.00 | ESR2 (1.00) | ESR2ESR1 | |
| SCHEMBL4853909 | 0.92 | ESR2 (0.85) | ESR2ESR1 | |
| SCHEMBL4850382 | 0.91 | ESR2 (0.83) | ESR2ESR1 | |
| SCHEMBL4851052 | 0.90 | ESR2 (0.81) | ESR2ESR1 | |
| SCHEMBL2419638 | 0.87 | ESR2 (1.00) | ESR2ESR1 | |
| SCHEMBL2415354 | 0.87 | ESR2 (1.00) | ESR2ESR1 | |
| SCHEMBL2417758 | 0.86 | ESR2 (1.00) | ESR2ESR1 | |
| SCHEMBL2419298 | 0.86 | ESR2 (0.76) | ESR2ESR1 | |
| SCHEMBL2420019 | 0.86 | ESR2 (0.76) | ESR2ESR1 | |
| SCHEMBL2413229 | 0.86 | ESR2 (1.00) | ESR2ESR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210254056-A1 | IDENTIFICATION AND TARGETED MODULATION OF GENE SIGNALING NETWORKS | CAMP4 THERAPEUTICS CORPORATION | 2021-08-19 | — | — | US | disclosed |
| US-20190192691-A1 | REGULATED BIOCIRCUIT SYSTEMS | OBSIDIAN THERAPEUTICS, INC. | 2019-06-27 | — | — | US | disclosed |